European Journal of Human Genetics

Papers
(The median citation count of European Journal of Human Genetics is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
A unique service: how an embedded psychology team can help patients and genetics clinicians within a clinical genetics service130
Hitting the heights with CiteScore101
Preferences for genetic testing among populations underrepresented in genomic research: a systematic review100
Clinical implementation of polygenic risk scores97
Commentary on Eichinger J, Zimmermann B, Elger B, McLennan S, Filges I, Koné I. 2023. ‘It’s a nightmare’: informed consent in paediatric genome-wide sequencing. A qualitative expert interview study fr92
Metaplastic breast cancer and BRCA1: first strong evidence of a link67
Perceptions of severity and their influence on reproductive decision-making following reproductive genetic carrier screening65
Utilization of automated cilia analysis to characterize novel INPP5E variants in patients with non-syndromic retinitis pigmentosa65
Germline NPAT inactivating variants as cause of hereditary colorectal cancer55
Ethical considerations for genetic research in low-income countries: perceptions of informed consent, data sharing, and expectations in Nicaragua52
Biallelic loss-of-function variants in ZNF142 are associated with a robust DNA methylation signature affecting a limited number of genomic loci48
Identification of biallelic POLA2 variants in two families with an autosomal recessive telomere biology disorder47
The Young Geneticists Network and the ESHG-Young committee, a forward-looking international community46
Ethics in editorship: lessons from a major retraction incident45
“I just wanted more”: Hereditary cancer syndromes patients’ perspectives on the utility of circulating tumour DNA testing for cancer screening43
A new multisystem ERCC1-hepatorenal syndrome: insights from a clinical cohort, molecular pathogenesis, and management guidelines43
Benign splenic lesions in BAP1-tumor predisposition syndrome: a case series42
View of healthcare professionals on ultra-rapid genome sequencing and its future implementation in clinical practice for critically ill children42
Expectations, needs and mid-term outcomes in people accessing to secondary findings from ES: 1st French mixed study (FIND Study)41
Panel testing for the molecular genetic diagnosis of congenital hypogonadotropic hypogonadism – a clinical perspective41
Genomic pathway managers: a novel role in the genomic medicine care pathway in France—overview and perspectives37
Expanding the phenotypic spectrum of NAA10-related neurodevelopmental syndrome and NAA15-related neurodevelopmental syndrome37
Genotype of PAX2-related disorders correlates with kidney and ocular manifestations36
Discovery of recessive effect of human polymerase δ proofreading deficiency through mutational analysis of POLD1-mutated normal and cancer cells35
Direct-to-consumer genetic testing: an updated systematic review of healthcare professionals’ knowledge and views, and ethical and legal concerns34
Defining ethical criteria to guide the expanded use of Noninvasive Prenatal Screening (NIPS): Lessons about severity from preimplantation genetic testing33
The first genetically confirmed cohort of Facioscapulohumeral Muscular Dystrophy from Northern India32
Abstracts from the 55th European Society of Human Genetics (ESHG) Conference: Hybrid Posters31
Correction: A framework for evaluating long-term impact of newborn screening31
Börjeson–Forssman–Lehmann syndrome: delineating the clinical and allelic spectrum in 14 new families31
Prevalence and natural history of schwannomas in neurofibromatosis type 2 (NF2): the influence of pathogenic variants30
Phenotypic subtypes of Xia-Gibbs syndrome: a latent class analysis30
Identification and characterization of two DMD pedigrees with large inversion mutations based on a long-read sequencing pipeline29
Dutch pharmacogenetics working group (DPWG) guideline for the gene–drug interaction between UGT1A1 and irinotecan27
Biallelic variants in the synaptic vesicle glycoprotein 2 A are associated with epileptic encephalopathy27
Comment on Gustavson syndrome is caused by an in-frame deletion in RBMX associated with potentially disturbed SH3 domain interactions26
Investigation of a pathogenic inversion in UNC13D and comprehensive analysis of chromosomal inversions across diverse datasets26
Osteopathia striata with cranial sclerosis: a new case supporting the link with bilateral Wilms tumor25
Genetic and allelic heterogeneity in 248 Indians with skeletal dysplasia25
Johann Gregor Mendel: the victory of statistics over human imagination25
A heterozygous 9q34 deletion encompassing SPTAN1 as a cause of distal myopathy25
Correction: Structural variant calling and clinical interpretation in 6224 unsolved rare disease exomes25
Exome sequencing reveals broad genetic heterogeneity for neuromuscular disorders in consanguineous Pakistani Families24
Expansion of the neurodevelopmental phenotype of individuals with EEF1A2 variants and genotype-phenotype study23
Missense variants in homeobox domain of PBX1 cause coracoclavicular ankylosis23
Exploring the ethics of genetic prioritisation for COVID-19 vaccines23
An integrated multiomic approach as an excellent tool for the diagnosis of metabolic diseases: our first 3720 patients23
Guidelines for genetic counselling supervision in Europe: a roadmap for ethical, effective, and reflective practice23
Ribonuclease inhibitor 1 (RNH1) deficiency cause congenital cataracts and global developmental delay with infection-induced psychomotor regression and anemia22
Correction: Slowly progressive autosomal dominant Alport Syndrome due to COL4A3 splicing variant22
What’s new in genetics in June 2022?22
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics22
Correction: Phenotypic subtypes of Xia-Gibbs syndrome: a latent class analysis22
Penetrance and pleiotropy in ATXN2-related amyotrophic lateral sclerosis21
Abstracts from the 57th European Society of Human Genetics (ESHG) Conference: Hybrid Posters21
Solving medical mysteries with genomics21
Editorial Déjà Vu: This time, it’s actually ‘what’s new in EJHG in May 2025?’21
Importance of critical thinking to understand ChatGPT20
POLD3 haploinsufficiency is linked to non-syndromic sensorineural adult-onset progressive hearing and balance impairments20
Confirmation and expansion of the phenotype of the TCEAL1-related neurodevelopmental disorder20
Demolishing the silo: towards team-based genomics in primary care20
Correction: Genetic discrimination still casts a large shadow in 202220
New Insight into the genotype-phenotype correlation of PTH1R variants and primary failure of tooth eruption on an Italian Cohort20
Young people’s experience of predictive genetic testing for inherited cardiac conditions: a qualitative study19
Heterozygous and homozygous variants in STX1A cause a neurodevelopmental disorder with or without epilepsy19
Exome sequencing as first-tier genetic testing in infantile-onset pharmacoresistant epilepsy: diagnostic yield and treatment impact19
Regional autozygosity association with albumin-to-creatinine ratio reveals a novel FTO region in an Indigenous Australian population18
Correction: Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction between UGT1A1 and irinotecan18
Prenatal Genome-Wide Sequencing analysis (Exome or Genome) in detecting pathogenic Single Nucleotide Variants in fetal Central Nervous System Anomalies: systematic review and meta-analysis18
Comparing 2D and 3D representations for face-based genetic syndrome diagnosis18
Should testing for mosaic genome-wide paternal uniparental disomy in Beckwith-Wiedemann spectrum (BWSp) be implemented in diagnostic testing?18
Concerns about the consequences of cancer predisposition and relationships with quality of life in young adults with Li-Fraumeni syndrome18
Episignature analysis of moderate effects and mosaics18
Attitudes of professional stakeholders towards implementation of reproductive genetic carrier screening: a systematic review18
Endometriosis - on the intersection of modern environmental pollutants and ancient genetic regulatory variants17
Trio-based exome sequencing reveals a high rate of the de novo variants in intellectual disability17
“Hypothesis: Patient with possible disturbance in programmed cell death”: further insights in pathogenicity and clinical features of Fraser syndrome17
Expanding the understanding of DDX3X-related neurodevelopmental disorder in males17
Koban culture genome-wide and archeological data open the bridge between Bronze and Iron Ages in the North Caucasus17
Recommendations for whole genome sequencing in diagnostics for rare diseases17
Determining a role for Patient and Public Involvement and Engagement (PPIE) in genomic data governance for cancer care17
A biallelic variant of DCAF13 implicated in a neuromuscular disorder in humans17
Spring in EJHG17
Comment on Informing relatives of their genetic risk: an examination of the Belgian context17
A rare genotype of biallelic mosaic variants in BCOR gene causing a bilateral ocular anterior segment dysgenesis and cataracts17
A second hotspot for pathogenic exon-skipping variants in CDC4516
Correction: A new blood DNA methylation signature for Koolen-de Vries syndrome: Classification of missense KANSL1 variants and comparison to fibroblast cells16
A yeast based assay establishes the pathogenicity of novel missense ACTA2 variants associated with aortic aneurysms16
Studying ultra-rare variants in STX1A uncovers a novel neurodevelopmental disorder16
Correction: Expansion of the neurodevelopmental phenotype of individuals with EEF1A2 variants and genotype-phenotype study16
Highly variable hearing loss due to POU4F3 (c.37del) is revealed by longitudinal, frequency specific analyses16
Craniofrontonasal syndrome in a patient with an inv(X)(p22.2q13.1), separating EFNB1 from its enhancer15
Consanguinity and willingness to perform premarital genetic screening in Sudan15
To sign or not to sign: Is this still the question?15
The absence of CFHR3 and CFHR1 genes from the T2T-CHM13 assembly can limit the molecular diagnosis of complement-related diseases15
Quality of life, illness perceptions, and parental lived experiences in TANGO2-related metabolic encephalopathy and arrhythmias15
The efficacy of genetic counselling for familial colorectal cancer. A randomised clinical trial15
Chromosome 20p11.2 deletions cause congenital hyperinsulinism via the loss of FOXA2 or its regulatory elements15
Correction: Myhre syndrome in adulthood: clinical variability and emerging genotype-phenotype correlations15
Constitutional copy number amplifications: rare or under-evaluated? Revisiting a 25-year-old cold case15
MINDDS-connect: a federated data platform integrating biobanks for meta cohort building and analysis15
The natural history of adults with Rubinstein-Taybi syndrome: a families-reported experience15
Assessing the digenic model in rare disorders using population sequencing data15
A homozygous frameshift variant in the CILK1 gene causes cranioectodermal dysplasia15
Pathogenic cryptic variants detectable through exome data reanalysis significantly increase the diagnostic yield in Joubert syndrome15
Analysis of large-language model versus human performance for genetics questions15
Assessing the contribution of genetic nurture to refractive error14
Copy number variants from 4800 exomes contribute to ~7% of genetic diagnoses in movement disorders, muscle disorders and neuropathies14
Correction to: High rate of HDR in gene editing of p.(Thr158Met) MECP2 mutational hotspot14
What is health and what do we mean when we say an intervention improves health?14
Assessing the unmet needs of genomic testing in Australia: a geospatial exploration14
CHAMP1-related disorders: pathomechanisms triggered by different genomic alterations define distinct nosological categories14
Role of ZFHX4 in orofacial clefting based on human genetic data and zebrafish models14
Negotiating severity behind the scenes: prenatal testing in Germany14
A tiered strategy to identify relevant genetic variants in familial pulmonary fibrosis: a proof of concept for the clinical practice14
Myhre syndrome in adulthood: clinical variability and emerging genotype-phenotype correlations14
What does a consent conversation for whole genome sequencing look like in the NHS Genomic Medicine Service? An observational study14
Reassessment of variants of uncertain significance in tumor suppressor genes using new ClinGen PP1/PP4 criteria guidance14
Germline variant in Ctcf links mental retardation to Wilms tumor predisposition14
A family with ulcerative colitis maps to 7p21.1 and comprises a region with regulatory activity for the aryl hydrocarbon receptor gene13
Diagnostic outcome of pro bono neurogenetic diagnostic service in Sri Lanka: A wealth creation13
Variable number tandem repeats (VNTRs) as modifiers of breast cancer risk in carriers of BRCA1 185delAG13
Risk perception and intended behavior change after uninformative genetic results for adult-onset hereditary conditions in unselected patients13
“The ability to get ahead”: Australian parent perspectives on genomics in newborn screening and considerations for potential models of care13
Genome sequencing enables diagnosis and treatment of SLC5A6 neuropathy13
The Spanish Polygenic Score reference distribution: a resource for personalized medicine13
Comparing saliva and blood for the detection of mosaic genomic abnormalities that cause syndromic intellectual disability13
Negotiating ‘severity’ in plain sight12
Proband-mediated interventions to increase disclosure of genetic risk in families with a BRCA or Lynch syndrome condition: a systematic review12
Multilocus Inherited Neoplasia Allele Syndrome (MINAS): an update12
Societal implications of expanded universal carrier screening: a scoping review12
Estimating the use of biological samples in Finnish biobanks and hospital collections12
Mild phenotypes in patients with different deletions in the 3′ enhancer region of SHOX12
“I am not a number!” Opinions and preferences of people with intellectual disability about genetic healthcare12
Novel PUF60 variant suggesting an interaction between Verheij and Cornelia de Lange syndrome: phenotype description and review of the literature12
Recessive variants in CACNB1: a new culprit in congenital myopathy. Expanding the genetic causes of excitation–contraction coupling disorders12
Germline pathogenic variants in HNRNPU are associated with alterations in blood methylome12
Knowledge, attitudes and demand toward cardiovascular polygenic risk testing in clinical practice: cross-sectional survey of patients12
Phenotypic compatibility and specificity in genomic variant classification12
Global trends and themes in genetic counseling research12
Becoming agents for genomic change: genetic counsellors’ views of patient care and implementation influences when genomics is mainstreamed12
Clinical and genetic analysis further delineates the phenotypic spectrum of ALDH1A3-related anophthalmia and microphthalmia12
Refining clinically relevant parameters for mis-splicing risk in shortened introns with donor-to-branchpoint space constraint12
Correction to: Genetics etiologies and genotype phenotype correlations in a cohort of individuals with central conducting lymphatic anomaly12
Molecular investigation in individuals with orofacial clefts and microphthalmia-anophthalmia-coloboma spectrum12
Machine learning predicts distinct biotypes of amyotrophic lateral sclerosis12
Developing genetic literacy in high school students with intellectual disability: Teachers’ experiences and perspectives12
Unrecognised actionability for breast cancer risk variants identified in a national-level review of Australian familial cancer centres12
‘Diagnostic shock’: the impact of results from ultrarapid genomic sequencing of critically unwell children on aspects of family functioning12
Novel phenotype of SIN3A-related disorder diagnosed in adulthood with multi-system involvement11
Exome sequencing of ATP1A3-negative cases of alternating hemiplegia of childhood reveals SCN2A as a novel causative gene11
Uncertainty, ethics, and progress in genomic medicine11
Genetic testing for monogenic forms of motor neuron disease/amyotrophic lateral sclerosis in unaffected family members11
Leave no one behind: inclusion of alpha-1 antitrypsin deficiency patients in COVID-19 vaccine trials11
Ten years of dynamic consent in the CHRIS study: informed consent as a dynamic process11
Early illustrations of the importance of systematic phenotyping11
Structural variation in nebulin and its impact on phenotype and inheritance: establishing a dominant distal phenotype caused by large deletions11
Genomic Balancing Act: deciphering DNA rearrangements in the complex chromosomal aberration involving 5p15.2, 2q31.1, and 18q21.3211
From screening to strategy: Clinical implications of COL4A3/COL4A4 variants found in reproductive genetic testing11
Returning individual research results in international direct-to-participant genomic research: results from a 31-country study11
Expanding the phenotypic spectrum of LIG4 pathogenic variations: neuro-histopathological description of 4 fetuses with stenosis of the aqueduct11
Considering severity in the design of reproductive genetic carrier screening programs: screening for severe conditions11
Abstracts from the 55th European Society of Human Genetics (ESHG) Conference: Oral Presentations11
Comment on Future trends in clinical genetic and genomic services by Borle et al.11
Rare autosomal trisomies detected by non-invasive prenatal testing: an overview of current knowledge11
GLA insufficiency should not be called Fabry disease11
An encounter with the mild side of LARS2-associated Perrault syndrome and its implications on the diagnostic odyssey11
A tool for translating polygenic scores onto the absolute scale using summary statistics11
Microsatellite instability in gastrointestinal cancers11
Whole exome and genome sequencing in mendelian disorders: a diagnostic and health economic analysis10
The utility of population level genomic research10
Clinical genomics testing: mainstreaming and globalising10
Genomic technologies identify milder presentations of Mendelian disease10
Improving diagnosis of mitochondrial fatty-acid oxidation disorders10
Loss of function of ADNP by an intragenic inversion10
Knowledge, attitudes and decision regret: a longitudinal survey study of participants offered genome sequencing in the 100,000 Genomes Project10
Scientific refutation of ESHG statement on embryo selection10
An analysis of genetically regulated gene expression and the role of co-expression networks across 16 psychiatric and substance use phenotypes10
POT1 tumour predisposition: a broader spectrum of associated malignancies and proposal for additional screening program10
The congenital hearing phenotype in GJB2 in Queensland, Australia: V37I and mild hearing loss predominates10
GWAS of lipids in Greenlanders finds association signals shared with Europeans and reveals an independent PCSK9 association signal10
FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women10
Are employees ready to engage in genetic cancer risk assessment in the workplace setting?10
Incorporating biobanking into the future of healthcare: exploring patient and healthcare worker perspectives at a Canadian tertiary academic hospital10
The cause of Jones syndrome put to REST: a mutation in the REST gene causes gingival fibromatosis and hearing loss10
De novo variants underlying monogenic syndromes with intellectual disability in a neurodevelopmental cohort from India10
Combined approaches, including long-read sequencing, address the diagnostic challenge of HYDIN in primary ciliary dyskinesia10
ParseCNV2: efficient sequencing tool for copy number variation genome-wide association studies9
Somatic and germinal mosaicism in a Han Chinese family with laminopathies9
Consent for genomic sequencing: a conversation, not just a form9
Genomic medicine in neonatal care: progress and challenges9
Emerging cancer risks in BRCA2 pathogenic germline variant carriers9
Rare-variant association analysis reveals known and new age-related hearing loss genes9
Diagnosis and management of vascular Ehlers-Danlos syndrome: Experience of the UK national diagnostic service, Sheffield9
A comprehensive SARS-CoV-2 and COVID-19 review, Part 2: host extracellular to systemic effects of SARS-CoV-2 infection9
The stepwise process of integrating a genetic counsellor into primary care9
Reassessment of FBN1 variants of uncertain significance using updated ClinGen guidance for PP1/BS4 and PP4 criteria9
Novel HSPB8 mutations in severe early-onset myopathy with involvement of respiratory and cardiac muscles cause proteostasis defects in cell models9
Host genetic basis of COVID-19: from methodologies to genes9
Genetic basis of osteogenesis imperfecta from a single tertiary centre in South Africa9
Beyond the hype: a comprehensive critique of ChatGPT’s applicability in genetics9
Correction to: The stepwise process of integrating a genetic counsellor into primary care9
GenCOLT: a multicenter European biobank for investigating genome-wide determinants of lung transplant outcomes9
Biallelic variants in CCN2 underlie an autosomal recessive kyphomelic dysplasia9
Summer reading 2025 in EJHG9
Down syndrome screening and diagnosis practices in Europe, United States, Australia, and New Zealand from 1990–20219
Predictive genetic testing for Motor neuron disease: time for a guideline?9
Recessive variants in WSB2 encoding a substrate receptor of E3 ubiquitin ligase underlie a neurodevelopmental syndrome9
Should non-invasive prenatal testing (NIPT) be used for fetal sex determination? Perspectives and experiences of healthcare professionals9
Genetic diagnosis for rare diseases in the Dutch Caribbean: a qualitative study on the experiences and associated needs of parents9
What’s new in EJHG in June 2024?9
A novel in-frame GFAP p.E138_L148del mutation in Type II Alexander disease with atypical phenotypes9
Opportunities and challenges for paediatricians requesting funded genomic tests for children9
Biallelic variants in RYR1 and STAC3 are predominant causes of King-Denborough Syndrome in an African cohort9
Interrupted CTG repeats in the 37–43 units size range in the 3ʹUTR of DMPK are common alleles9
Workshop report: the clinical application of data from multiplex assays of variant effect (MAVEs), 12 July 20239
CDK13-related disorder: a deep characterization of speech and language abilities and addition of 33 novel cases8
STRavinsky STR database and PGTailor PGT tool demonstrate superiority of CHM13-T2T over hg38 and hg19 for STR-based applications8
Polygenic risk modeling for prediction of epithelial ovarian cancer risk8
Contributing to the on-going debate around the clinical application of preimplantation embryo selection based on polygenic risk scores (PGT-P)8
A successful conclusion to the long search for TRPV5 pathogenic variants in monogenic hypercalciuria8
Research participants: critical friends, agents for change8
Autistic perspectives on the moral and ethical considerations of genetic testing for autism8
Myeloid neoplasms risks for germline DDX41 pathogenic variants carriers8
Impact of rapid genomic testing on clinical outcomes of acutely unwell children presenting with severe epilepsy8
Surveillance of multiple congenital anomalies; searching for new associations8
WDR45-related encephalopathy mimicking Leigh syndrome associated with complex I deficiency: a case report8
Singleton exome sequencing of 90 fetuses with ultrasound anomalies revealing novel disease-causing variants and genotype–phenotype correlations8
A new impact factor for EJHG in 20228
Bi-allelic MYMX variants cause a syndromic congenital myopathy with recognizable facial palsy, growth restriction, and dysmorphism8
PKD1 5’UTR variants are a rare cause of disease in ADPKD and suggest a new focus for therapeutic development8
Experiences of nonpregnant couples after receiving reproductive genetic carrier screening results in Belgium8
Missense mutation of MAL causes a rare leukodystrophy similar to Pelizaeus-Merzbacher disease8
Publics’ knowledge of, attitude to and motivation towards health-related genomics: a scoping review8
KiT-GENIE, the French genetic biobank of kidney transplantation8
DNA methylation episignature for Smith-Magenis and Potocki-Lupski syndromes: a mirror perspective8
EMD missense variant causes X-linked isolated dilated cardiomyopathy with myocardial emerin deficiency8
Expanding the speech and language phenotype in Koolen-de Vries syndrome: late onset and periodic stuttering a novel feature8
A new blood DNA methylation signature for Koolen-de Vries syndrome: Classification of missense KANSL1 variants and comparison to fibroblast cells8
LARS2 variants can present as premature ovarian insufficiency in the absence of overt hearing loss8
Reevaluating ‘seriousness’ in genetic conditions: balancing clinical criteria and lived experiences8
A novel nonsense variant in the CENPP gene segregates in a Swiss family with autosomal dominant low-frequency sensorineural hearing loss8
ADNP in reverse gear8
Molecular explanations for variability of clinical phenotypes8
Validity of European-centric cardiometabolic polygenic scores in multi-ancestry populations8
Exome sequencing identifies HELB as a novel susceptibility gene for non-mucinous, non-high-grade-serous epithelial ovarian cancer8
Genetic counselling and testing for neurodegenerative disorders using a proposed standard of practice for ALS/MND: diagnostic testing comes first8
Two for the heart: Dutch Pharmacogenetic Working Group prescribing guidance on statins and sulfonylureas to reduce cardiometabolic risk8
Reanalysis of clinical exome identifies the second variant in two individuals with recessive disorders8
Biallelic SH2B3 germline variants are associated with a neonatal myeloproliferative disease and multisystemic involvement8
0.13835716247559